MMMariya Marushchak

Mariya Marushchak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mariya Marushchak has a total of 199 co-authors. Here are the top co-authors by number of shared publications:

  • Inna Krynytska

    Department of Functional and Laboratory Diagnostics , I Horbachevsky Ternopil National Medical University , Ternopil , Ukraine

    26 shared publications
  • Inna Krynytska

    I. Horbachevsky Ternopil National Medical University

    13 shared publications
  • Lyudmyla Mazur

    Department of Higher Nursing Education, Patient Care and Clinical Immunology , I. Horbachevsky Ternopil National Medical University , Ternopil , Ukraine

    6 shared publications
  • Ivan Klishch

    Functional and Laboratory Diagnosis Department, I. Horbachevsky Ternopil State Medical University, Ternopil, Ukraine

    5 shared publications
  • Kateryna Kozak

    Department of Pediatrics No. 2, I. Horbachevsky Ternopil National Medical University , Ternopil , Ukraine

    4 shared publications
  • Uliana Hevko

    4 shared publications

Latest Publications

  • Open Access

    ANALYSIS OF INPATIENT ACTIVITY AND HEALTHCARE STAFFING UNDER CONTEMPORARY REFORMS: EXPERIENCE OF THE VOLODYMYR TERRITORIAL MEDICAL ASSOCIATION

    by Tetiana P. Vashchuk, Petro H. Lykhatskyi, Mariia I. Marushchak

    Introduction. Transformation of healthcare financing and hospital networks in Ukraine requires assessment of how changes in inpatient capacity are associated with bed utilization and workforce availability. Aim. To evaluate trends in inpatient care volume, hospital bed utilization, and staffing at the Municipal Enterprise “Volodymyr Territorial Medical Association” of the Volodymyr City Council from 2021 to 2025. Materials and methods. A single-center retrospective longitudinal observational study used aggregated annual data from official statistical reporting Form No. 20. The calendar year was the unit of analysis. Staffing rates, bed occupancy, average length of stay, bed turnover, and in-hospital mortality were calculated. Temporal dynamics were assessed using Pearson and Spearman correlation coefficients; the linear mortality trend was tested with the Cochran–Armitage test, and heterogeneity of annual proportions with the Pearson χ² test. Statistical significance was set at 0.05. Results. From 2021 to 2025, the average annual number of beds increased from 280 to 520, admissions from 9,150 to 16,971, discharges from 8,833 to 16,634, and bed-days from 75,075 to 135,257. The corresponding increases were 85.7%, 85.5%, 88.3%, and 80.2%. Average length of stay ranged from 7.2 to 8.2 days, bed turnover from 27.5 to 32.9 patients per bed annually, and bed occupancy from 55.6% to 73.5%; no statistically significant monotonic trend was identified. In-hospital mortality was 3.35% in 2021, 1.27% in 2024, and 1.81% in 2025. The Cochran–Armitage test identified a negative linear component (z=−8.004; p<0.001), and the Pearson χ² test showed between-year heterogeneity (p<0.001), whereas the rank trend across the five annual proportions was not statistically significant. The physician staffing rate increased from 81.73% to 91.38%, while the staffing rate for nursing personnel did not change materially. Conclusions. Expansion of inpatient capacity was accompanied by a proportionate increase in patient flow without sustained deterioration in bed utilization indicators. Positive workforce dynamics primarily concerned physician positions. Analyses by department, diagnosis, case severity, and episode of care are required to support more specific managerial decisions.

  • Open Access

    Characteristics of patients with type 2 diabetes mellitus with different levels of adherence to pharmacotherapy

    by S. A. Skrypka, M. I. Marushchak, A. S. Volska, O. P. Mialiuk

    Research indicates that the issue of adherence is multifactorial in nature and requires a comprehensive assessment within each specific patient population since the structure of the determinants may vary significantly depending on the socio-economic context, access to healthcare and the specific organization of the healthcare system in different countries. Aim. To assess the level of adherence to pharmacotherapy among patients with type 2 diabetes mellitus and identify the main clinical, demographic and socio-psychological factors that affect it in order to inform strategies for improving the effectiveness of the drug treatment for this patient group. Materials and methods. A single-center cohort study was conducted; it involved 120 patients with a confirmed diagnosis of type 2 diabetes who were under outpatient care and received hypoglycemic pharmacotherapy. To assess the structure of pharmacotherapy, the main groups of hypoglycemic agents were taken into account. The level of adherence to pharmacotherapy was determined using the validated Medication Adherence Report Scale questionnaire. Results and discussion. The study cohort was predominantly comprised of older patients, both men and women, with a long-standing history of type 2 diabetes and a high prevalence of comorbid conditions. Almost half of the patients were taking five or more medicines per day, creating conditions for polypharmacy and reduced adherence to treatment. The most commonly used medicines were metformin, statins and antihypertensive drugs. A significant proportion of the patients examined received the combination therapy, which was due to the presence of obesity, hypertension, dyslipidaemia and other comorbidities. Conclusions. In patients with type 2 diabetes mellitus, an insufficient level of adherence to pharmacotherapy was observed (32.0 % – high, 38.8 % – moderate and 29.2 % – low levels). Low adherence to pharmacotherapy was significantly associated with older age (64.3 ± 4.8 years), longer duration of the disease (11.3 ± 6.0 years), polypharmacy (≥ 5 medicines per day) and complex medication regimens.

  • Open Access

    Association Between Audiometric Indicators and Clinical and Functional Characteristics in Patients with Chronic Obstructive Pulmonary Disease

    by O. Semerez, M. Marushchak

    Introduction. Most studies of chronic obstructive pulmonary disease (COPD) are limited to information regarding the quantitative relationship between tonal audiometry parameters and the severity of bronchial obstruction according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification. The aim of the study. To analyse the mean hearing threshold in patients with chronic obstructive pulmonary disease according to the Global Initiative for Chronic Obstructive Lung Disease staging system and to establish its correlation with clinical and functional parameters. Materials and methods. The study included 100 patients with COPD who were receiving inpatient treatment. The diagnosis of COPD was established in accordance with the GOLD recommendations (2024). Hearing function was assessed using pure-tone threshold audiometry with the Auditus A1. During the study, age, sex, smoking status, smoking intensity and body mass index (BMI) were assessed. Statistical analysis was performed using Statistica 13.0 software. Results. It was found that, in patients with COPD, the pure tone average (PTA) value increased progressively in line with the severity of the disease in both the right and left ears. The distribution of patients by degree of hearing loss shows a clear correlation with the severity of COPD. Correlation analysis revealed a strong association between PTA and smoking history and forced expiratory volume in 1 second, as well as a moderate association with arterial oxygen saturation and age. By contrast, the association between PTA and BMI, COPD duration and frequency of exacerbations was not statistically significant. Conclusions. In patients with chronic obstructive pulmonary disease, the pure tone average increases significantly bilaterally in accordance with the stage of the disease, with a corresponding increase in the proportion of patients with Grade I hearing loss from 6.90 % in GOLD Stage I to 100.00 % in GOLD Stage IV (χ² = 45.61; p < 0.001). A strong, statistically significant association was found between the pure tone average and indicators reflecting the severity of bronchial obstruction and smoking history, as well as a negative moderate association with arterial oxygen saturation and positive - with age.

  • Open Access

    COMPREHENSIVE ASSESSMENT OF FACTORS ASSOCIATED WITH THE PROGRESSION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

    by O.V. Semerez, M.I. Marushchak

    Introduction. The significant clinical heterogeneity of chronic obstructive pulmonary disease (COPD) manifests itself in various phenotypes, rates of progression, and responses to treatment. Since the clinical course of COPD is multifactorial, it is necessary to consider not only spirometry parameters but also clinical, laboratory, and comorbid factors when predicting disease progression. Aim - to identify patterns of changes in pulmonary function and blood oxygenation parameters in patients with COPD depending on disease stage and clinical and epidemiological characteristics. Materials and Methods. The study included 100 patients with COPD who were receiving inpatient or outpatient care at the Ternopil Regional Clinical Hospital. The diagnosis of COPD was established in accordance with the recommendations of the Global Initiative for Chronic Obstructive Lung Disease (GOLD, 2024) based on clinical manifestations, medical history, and spirometry results. All patients were divided into four groups based on the severity of bronchial obstruction according to the GOLD classification: Group 1—Stage I (GOLD 1)—29 patients; Group 2—Stage II (GOLD 2)—39 patients; Group 3 – Stage III (GOLD 3) – 24 patients; Group 4 – Stage IV (GOLD 4) – 8 patients. The study analyzed the demographic, clinical, and anthropometric characteristics of the patients. Statistical analysis was performed using Statistica 13.0. Results. A decrease in the FEV₁ value was observed, from 90.66±5.56% in Stage I to 23.13±4.26% in Stage IV COPD (p 0.05). COPD severity is significantly associated with increased smoking history (r = 0.53; p < 0.001) and a decrease in pulmonary function parameters (FEV₁: r = −0.95; p < 0.001) and blood oxygenation (SpO₂: r = −0.71; p < 0.001). Tobacco exposure correlates negatively with FEV₁ (r = −0.54; p < 0.001) and SpO₂ (r = −0.44; p < 0.001), whereas a strong positive correlation was found between FEV₁ and SpO₂ (r = 0.67; p < 0.001). Conclusions. The most informative approach in COPD is a comprehensive evaluation of patients that takes into account functional parameters (FEV₁, SpO₂), tobacco exposure, laboratory markers of systemic inflammation, and other clinical parameters, which allows for a more accurate assessment of COPD severity, prediction of disease progression, and optimization of treatment strategies.

  • Open Access

    THE QUALITY OF HEALTHCARE SERVICES AND ITS ASSOCIATED FACTORS AMONG PEOPLE WITH TYPE 2 DIABETES IN CHINA

    by Xiang Yifu, M. I. Marushchak

    Purpose: to comprehensively analyse the patterns of health care utilization among patients with T2DM in China, with particular attention to access to medical services, frequency and level of care and the influence of socioeconomic, demographic, and regional factors on health care-seeking behavior. Materials and methods. This review article is based on an analysis of current scientific publications, international analytical reports and public health policy documents. Sources were identified using scientometric databases as well as official websites of international organisations. The analysis included systematic reviews, meta-analyses, analytical reports and policy documents that addressed the epidemiology of mental disorders, their prevention, the overcoming of stigma, intersectoral collaboration and the role of public health professionals in healthcare services. The study's methodological basis was the systematisation of scientific data to identify key areas of activity for public health professionals in the use of healthcare services. Results. Healthcare utilization among individuals with T2DM in China includes outpatient visits, inpatient admissions, pharmacotherapy, and engagement with primary care services. The Chinese health care system has made substantial progress in addressing type 2 diabetes mellitus through expanded insurance coverage, national public health programs, and clinical guideline implementation. However, persistent challenges ‒ including regional disparities, limited primary care capacity, self-care programs and rising disease prevalence ‒ continue to hinder optimal disease management. Strengthening primary care, improving financial protection, and leveraging digital health solutions are critical for enhancing diabetes care in China. Conclusіons. Strengthening primary care systems, reducing financial barriers, improving patient education, and integrating digital health technologies are essential strategies for optimizing healthcare utilization and improving outcomes in patients with type 2 diabetes mellitus.

  • Open Access

    Chronic pain: contemporary concepts and epidemiology

    by Svetlana Aynbinder, Mariya Marushchak

    Introduction. The lack of scientific understanding of the epidemiology of chronic pain has led to significant disparities in the allocation of healthcare resources, including a shortage of statistical data and epidemiological studies on chronic pain. The aim of the study – to analyze contemporary concepts of chronic pain and to summarize current scientific data on its prevalence, epidemiological trends, and impact on quality of life and healthcare systems. The main part. The study analysed current scientific publications and reports from web-cites and international organisations, in particular the World Health Organisation, available on the Internet. Epidemiological studies show that chronic pain is widespread worldwide: on average, around one in five people suffer from this condition. The findings of numerous studies indicate a substantial burden of pain in Europe and the United States. Earlier studies estimated the global prevalence of chronic pain to be approximately 20 %, suggesting that nearly 1.6 billion people worldwide are affected by this condition. Unfortunately, it is very difficult to estimate the economic losses in Ukraine at present, but it can be assumed that the scale is comparable to that observed in other European countries. Conclusion. Chronic pain is a highly prevalent and multifactorial public health problem that significantly affects physical health, mental well-being, and quality of life. Epidemiological evidence highlights the growing burden of chronic pain worldwide and underscores the importance of comprehensive prevention and management strategies. Understanding the epidemiological patterns and determinants of chronic pain is essential for improving healthcare policies, optimizing clinical care, and reducing the social and economic consequences associated with chronic pain conditions.

  • Open Access

    CLINICAL AND LABORATORY MARKERS OF CHOLEDOCHOLITHIASIS AND ITS COMPLICATIONS

    by N.M. Ostrovskyy, O.E. Okseniuk, A.M. Sergeіeva, M.I. Marushchak, O.P. Mialiuk

    The clinical presentation of choledocholithiasis can vary considerably, as inflammation of the bile ducts can be asymptomatic (up to half of cases) or associated with a variety of symptoms and conditions, ranging from colic to potentially life-threatening complications such as ascending cholangitis, biliary pancreatitis, etc.The purpose of the study is to analyze current data on clinical and laboratory markers used for the diagnosis of choledocholithiasis and its complications.The study was based on analyzing scientific sources of information on the specified topic.Retrospective studies have shown that the combination of serum bilirubin, gamma-glutamyl transpeptidase, alkaline phosphatase, and patient age has a high prognostic value for the presence of biliary stones. Inflammatory markers are particularly important, including interleukin-6, which has been shown to be more accurate in detecting necrotic forms of acute biliary pancreatitis early in the disease than traditional C-reactive protein. It has also been found that liver function tests, such as alanine aminotransferase, may be useful in differentiating the biliary etiology of pancreatitis, although their sensitivity is limited. The use of computed tomography, especially with contrast, remains an important tool for visualizing complications, although its sensitivity in the early stages of the disease may be insufficient. Laboratory markers also include urinary trypsinogen-2 and polymorphonuclear leukocyte elastase, but their clinical availability is limited.The use of a combination of biochemical and instrumental studies allows to increase the accuracy of choledocholithiasis diagnosis and prediction of complications, which is of key importance for choosing an adequate treatment strategy and reducing the risk of serious consequences. Клінічна картина холедохолітіазу може значно варіюватися, оскільки запалення жовчних проток може бути безсимптомним (до половини випадків) або пов'язаним з різними симптомами та станами, починаючи від колік до потенційно небезпечних для життя ускладнень, таких як висхідний холангіт, біліарний панкреатит і т. д.Мета дослідження – проаналізувати сучасні дані щодо клініко-лабораторних маркерів, які використовуються для діагностики холедохолітіазу та його ускладнень. Дослідження ґрунтувалося на аналізі наукових джерел інформації із заданої тематики.Ретроспективні дослідження демонструють, що комбінація показників сироваткового білірубіну, гамма-глутамілтранспептидази, лужної фосфатази та віку пацієнта має високу прогностичну цінність для визначення наявності каменів у жовчовивідних шляхах. Особливо важливими є маркери запалення, зокрема інтерлейкін-6, який у ранні терміни захворювання показує більшу точність у виявленні некротичних форм гострого біліарного панкреатиту у порівнянні з традиційним С-реактивним білком. Також встановлено, що оцінка печінкових проб, таких як аланінамінотрансфераза, може бути корисною для диференціації біліарної етіології панкреатиту, хоча має обмежену чутливість. Застосування комп’ютерної томографії, особливо з контрастуванням, залишається важливим інструментом для візуалізації ускладнень, хоча її чутливість у ранні терміни хвороби може бути недостатньою. Серед лабораторних маркерів виділяються також трипсиноген-2 у сечі і поліморфноядерна лейкоцитарна еластаза, проте їх клінічна доступність обмежена.Застосування комбінації біохімічних та інструментальних досліджень дозволяє підвищити точність діагностики холедохолітіазу і прогнозування ускладнень, що має ключове значення для вибору адекватної лікувальної стратегії та зниження ризику тяжких наслідків.

  • Open Access

    THE IMPACT OF COVID-19 ON MENTAL HEALTH AS PART OF GLOBAL HEALTH

    by Y. Wang, H. H. Habor, А. С. Вольська, M. I. Marushchak, Ю. Ван, Г. Г. Габор

    Objective. To analyse the impact of COVID-19 on mental health in different countries and globally. Materials and methods. The study analysed current scientific publications and reports from international organisations, in particular the World Health Organisation, available on the Internet. Results. The pandemic’s effect on mental health was multifaceted, driven by a combination of social, economic, and health-related stressors. Numerous studies from around the world have documented the sharp rise in mental health issues during the pandemic. This lack of social connection disrupted daily routines and support systems, contributing to feelings of loneliness and depression. The economic fallout of the pandemic was a major contributor to anxiety and depression, particularly for vulnerable populations. The immense pressure, long hours, and emotional toll of their work led to high rates of anxiety, depression, and post-traumatic stress disorder among the healthcare workers. The “infodemic” made it difficult for people to make informed decisions and increased feelings of helplessness. The profound mental health toll of the COVID-19 pandemic is expected to have long-lasting effects, extending far beyond the resolution of the physical health crisis. This has made it crucial to not only respond to immediate needs but to also fundamentally re-evaluate and “reimagine” mental healthcare delivery. Conclusions. The COVID-19 pandemic served as a global stress test for mental health, exposing deep-seated vulnerabilities within societies. The widespread fear, social isolation, and economic instability created a perfect storm for a global mental health crisis. As the world moves into a post-pandemic era, it is critical for public health systems to recognize mental health as a core component of overall health and to invest in resilient, accessible, and integrated mental health services.

  • The impact of optimism on the quality of life in patients with copd

    by Оksana Mialiuk, Oksana Okseniuk, Volodymyr Bondar, Mariya Marushchak, Liudmyla Herasymenko, Pavlina Nevhadovska

  • Open Access

    PSYCHOLOGICAL CHARACTERISTICS OF PATIENTS WITH COVID-19 ASSOCIATED PNEUMONIA

    by Jiuyuan Peng, M. I. Marushchak, H. H. Habor, H. I. Klishch, L. P. Mazur

    Introduction. Patients with COVID-19 often face a wide range of psychological features that can persist for a long time after the acute phase of the disease. Numerous studies have shown an increased prevalence of mental disorders among people with COVID-19 compared to the general population or patients with other respiratory diseases. The aim of the study – to analyse the level of optimism/pessimism among patients with COVID-19 pneumonia depending on the category of disease severity. The main part. The first stage of our study was a retrospective examination of the medical records of 27 patients who were hospitalized for community-acquired pneumonia (confirmed by computed tomography) with a positive smear test result for SARS-CoV-2 virus. The severity of pneumonia was calculated using the PORT scale. The second stage of our study was a telephone survey to assess the level of optimism of the participants of the first stage of our study 6-12 months after discharge from the hospital, using The Life Orientation Test-Revised. Assessment of the level of optimism in patients with COVID-19-associated pneumonia shows a decrease in its level with an increase in the category of pneumonia complexity. At the same time, in group III, the level of optimism was significantly lower by 26.2 % compared with the comparison group. It is worth noting a significant increase in the percentage of people with high pessimism and, accordingly, a decrease in the percentage of people with high optimism as COVID-19-associated pneumonia progresses. The analysis of optimism components showed the vast majority of positive responses to the statement ‘In uncertain times, I usually expect the best’ in group II (92.31 %) and group III (71.42 %) and the largest number of negative responses to the statement ‘I’m always optimistic about my future’ in group III (50.00 %). The analysis of pessimism components showed the vast majority of affirmative responses to the statements ‘I hardly ever expect things to go my way’ (78.56 %), ‘I rarely count on good things happening to me’ (71.94 %) in group III patients, which, however, did not significantly differ from the data in group II patients. Conclusions. Understanding psychological characteristics is critical to developing effective diagnostic, treatment and rehabilitation strategies aimed at improving the mental health and quality of life of individuals after COVID-19-associated pneumonia.